KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors

Laboratory Investigation

Volumn 78, Issue 12, 1998, Pages 1633-1636

  Ernst, Susanne I ^a   Hubbs, Alan E ^a   Przygodzki, Ronald M ^a   Emory, Theresa S ^a   Sobin, Leslie H ^a   O'Leary, Timothy J ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA SEQUENCE; GASTROINTESTINAL TUMOR; GENE MUTATION; HUMAN; HUMAN CELL; MITOSIS INDEX; MUSCLE TUMOR; ONCOGENE C KIT; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AMINO ACID SEQUENCE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MITOTIC INDEX; MOLECULAR SEQUENCE DATA; NEOPLASMS, CONNECTIVE TISSUE; POINT MUTATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; SEQUENCE DELETION; SMOOTH MUSCLE TUMOR; STOMACH NEOPLASMS; STROMAL CELLS; SURVIVAL RATE;

EID: 0032408616     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Appelman HD (1986). Smooth muscle tumors of the gastrointestinal tract: What we know now that Stout didn't know. Am J Surg Pathol 10(Suppl 1):83-99.
2. Appleman HD and Helwig EB (1976). Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 38:708-728.
3. Bellone G, Silvestri S, Artusio E, Tibaudi D, Turletti A, Geuna M, Giachino C, Valente G, Emanuelli G, and Rodeck U (1997). Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol 172:1-11.
4. Blechman JM, Lev S, Brizzi MF, Leitner O, Pegoraro L, Givol D, and Yarden Y (1993). Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. J Biol Chem 268:4399-4406.
5. Cai J, Jiang Y, Zhang Y, Lu G, Zhang X, Gao Q, and Zuo L (1995). Quantitation of P53 protein expression in gastrointestinal smooth muscle tumors: Clinicopathological correlation and prognostic significance. Chin Med J (Engl) 108:669-673.
6. Chou FF, Eng HL, and Sheen-Chen SM (1996). Smooth muscle tumors of the gastrointestinal tract: Analysis of prognostic factors. Surgery 119:171-177.
7. Cooper PN, Quirke P, Hardy GJ, and Dixon MF (1992). A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol 16: 163-170.
8. Cunningham RE, Federspiel BH, McCarthy WF, Sobin LH, and O'Leary TJ (1993). Predicting prognosis of gastrointestinal smooth muscle tumors: Role of clinical and histologic evaluation, flow cytometry, and image cytometry. Am J Surg Pathol 17:588-594.
9. el-Naggar AK, Ro JY, McLemore D, Garnsey L, Ordonez N, and Mackay B (1989). Gastrointestinal stromal tumors: DNA flow-cytometric study of 58 patients with at least five years of follow-up. Mod Pathol 2:511-515.
10. el-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, and Andersson LC (1996). DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors. Cancer Res 56:3230-3233.
11. Emory TS, Lukes L, Lee D, Sobin LH, and O'Leary TJ (in press, 1998). Prognosis of gastrointestinal smooth muscle tumors: Dependence on site of origin. Am J Surg Pathol.
12. Evans HL (1985). Smooth muscle tumors of the gastrointestinal tract: A study of 56 cases followed for a minimum of 10 years. Cancer 56:2242-2250.
13. Franquemont DW and Frierson HF Jr (1995). Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod Pathol 8:473-477.
14. Franquemont DW and Geary WA (1993). Gastrointestinal stromal tumors and proliferating cell nuclear antigen: Prognostic challenges (editorial). Am J Clin Pathol 100:369-370.
15. Goldblum JR and Appelman HD (1995). Stromal tumors of the duodenum: A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 19:71-80.
16. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, and Kitamura Y (1998). Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580.
17. Kiyabu MT, Bishop PC, Parker JW, Turner RR, and Fitzgibbons PL (1988). Smooth muscle tumors of the gastrointestinal tract: Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade. Am J Surg Pathol 12:954-960.
18. Koga H, Ochiai A, Nakanishi Y, Sasako M, Mizuno S, Kinoshita T, Maruyama K, and Hirohashi S (1995). Reevaluation of prognostic factors in gastric leiomyosarcoma. Am J Gastroenterol 90:1307-1312.
19. Lee JS, Nascimento AG, Farnell MB, Carney JA, Harmsen WS, and llstrup DM (1995). Epithelioid gastric stromal tumors (leiomyoblastomas): A study of fifty-five cases. Surgery 118: 653-660.
20. Lerma E, Lee SJ, Tugues D, Oliva E, Gich I, and Prat J (1994a). Ploidy of 36 stromal tumors of the gastrointestinal tract: A comparative study with flow cytometry and image analysis. Anal Quant Cytol Histol 16:435-440.
21. Lerma E, Oliva E, Tugues D, and Prat J (1994b). Stromal tumours of the gastrointestinal tract: A clinicopathological and ploidy analysis of 33 cases. Virchows Arch 424:19-24.
22. Oyama T, Watanabe H, Iwafuchi M, Maejima T, and Ajioka Y (1993). Diagnostic value of proliferating cell nuclear antigen for myogenic tumors of the stomach. Gastroenterol Jpn 28:193-200.
23. Ranchod M and Kempson RL (1977). Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: A pathologic analysis of 100 cases. Cancer 39:255-262.
24. Ray R, Tahan SR, Andrews C, and Goldman H (1994). Stromal tumors of the stomach: Prognostic value of the PCNA index. Mod Pathol 7:26-30.
25. Reid AH, Tsai MM, Venzon DJ, Wright CF, Lack EE, and O'Leary TJ (1996). MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma. Diagn Mol Pathol 5:65-73.
26. Roy M and Sommers SC (1989). Metastatic potential of gastric leiomyosarcoma. Pathol Res Pract 185:874-877.
27. Sarlomo-Rikala M, el-Rifai W, Lahtinen T, Andersson LC, Miettinen M, and Knuutila S (1998). Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. Hum Pathol 29:476-481.
28. Sbaschnig RJ, Cunningham RE, Sobin LH, and O'Leary TJ (1994). Proliferating-cell nuclear antigen immunocytochemistry in the evaluation of gastrointestinal smooth-muscle tumors. Mod Pathol 7:780-783.
29. Shimamoto T, Haruma K, Sumii K, Kajiyama G, and Tahara E (1992). Flow cytometric DNA analysis of gastric smooth muscle tumors. Cancer 70:2031-2034.
30. Shimamoto T, Haruma K, Tanaka S, Todo H, Yoshihara M, Sumii K, and Kajiyama G (1993). Usefulness of nucleolar organizer region staining in gastric myogenic tumors: Correlation with ploidy by DNA flow cytometry. Oncology 50:52-56.
31. Suzuki H and Sugihira N (1993). Prognostic value of DNA ploidy in primary gastric leiomyosarcoma. Br J Surg 80: 1549-1550.
32. Tsushima K, Rainwater LM, Goellner JR, van Heerden JA, and Lieber MM (1987). Leiomyosarcomas and benign smooth muscle tumors of the stomach: Nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 62:275-280.
33. Tworek JA, Appelman HD, Singleton TP, and Greenson JK (1997). Stromal tumors of the jejunum and ileum. Mod Pathol 10:200-209.
34. Vrettou E, Karkavelas G, Christoforidou B, Meditskou S, and Papadimitriou CS (1995). Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors. Anticancer Res 15:943-949.
35. Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, and Cornelisse CJ (1992). Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue (see comments). J Pathol 168:75-83.